WO2009053549A8 - Le solvate de dmso de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant - Google Patents
Le solvate de dmso de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant Download PDFInfo
- Publication number
- WO2009053549A8 WO2009053549A8 PCT/FR2008/001158 FR2008001158W WO2009053549A8 WO 2009053549 A8 WO2009053549 A8 WO 2009053549A8 FR 2008001158 W FR2008001158 W FR 2008001158W WO 2009053549 A8 WO2009053549 A8 WO 2009053549A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- same
- rimonabant
- pharmaceutical compositions
- compositions containing
- dmso solvate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention concerne le solvate de DMSO de rimonabant, son procédé de préparation et ses utilisations thérapeutiques.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0756960 | 2007-08-06 | ||
| FR0756960A FR2919865A1 (fr) | 2007-08-06 | 2007-08-06 | Le solvate de dmso de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2009053549A1 WO2009053549A1 (fr) | 2009-04-30 |
| WO2009053549A8 true WO2009053549A8 (fr) | 2009-07-23 |
Family
ID=39144334
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/FR2008/001158 Ceased WO2009053549A1 (fr) | 2007-08-06 | 2008-08-04 | Le solvate de dmso de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant |
Country Status (2)
| Country | Link |
|---|---|
| FR (1) | FR2919865A1 (fr) |
| WO (1) | WO2009053549A1 (fr) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2713225B1 (fr) * | 1993-12-02 | 1996-03-01 | Sanofi Sa | N-pipéridino-3-pyrazolecarboxamide substitué. |
| FR2761265B1 (fr) * | 1997-03-28 | 1999-07-02 | Sanofi Sa | Composition pharmaceutique pour l'administration orale d'un derive du n-piperidino-3-pyrazolecarboxamide, de ses sels et de leurs solvates |
| FR2831883B1 (fr) * | 2001-11-08 | 2004-07-23 | Sanofi Synthelabo | Forme polymorphe du rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant |
-
2007
- 2007-08-06 FR FR0756960A patent/FR2919865A1/fr active Pending
-
2008
- 2008-08-04 WO PCT/FR2008/001158 patent/WO2009053549A1/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| FR2919865A1 (fr) | 2009-02-13 |
| WO2009053549A1 (fr) | 2009-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2008051942A3 (fr) | Agonistes du récepteur farnésoïde x | |
| HK1259250A1 (zh) | 包含1-(β-D-吡喃葡萄糖基)-2-噻吩基-甲基苯衍生物的药物制剂 | |
| HUE072202T2 (hu) | Eltrombopag-olamint tartalmazó tabletták | |
| ZA201001015B (en) | (Carboxylalkylene-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament | |
| IL204556A0 (en) | (cyclopropyl-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament | |
| IL193772A0 (en) | 4-oxoquinoline derivatives,methods for the preparation thereof and pharmaceutical compositions containing the same | |
| IL206394A (en) | Derivatives of 2-Benzylpyridine Filtration as Met Kinase Inhibitors, Process for their Preparation, Medication and Use | |
| AP2384A (en) | 1,2,4,5-tetrahydro-3H-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| AP2010005343A0 (en) | New dihydroindolone compounds, a process for theirpreparation and pharmaceutical compositions conta ining them. | |
| EP2201011A4 (fr) | Nouveaux composés présentant des squelettes d'indazole, méthodes de préparation de ceux-ci et composition pharmaceutique les contenant | |
| WO2009055289A3 (fr) | Lactames substitués à usage thérapeutique | |
| WO2008129501A3 (fr) | Compositions pharmaceutiques de duloxetine | |
| IL186062A (en) | Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same | |
| PT2231598E (pt) | Novos derivados diazéniodiolato, processo para a sua preparação e as composições farmacêuticas que os contenham | |
| IL186862A0 (en) | Novel phenyl-pyridinyl-piperazine derivatives, a method for the production thereof and pharmaceutical compositions containing said derivatives | |
| WO2009026257A8 (fr) | Procédés et compositions pour contrôler la biodisponibilité de médicaments faiblement solubles | |
| WO2006081515A3 (fr) | Polymorphes d'hydrochlorure de duloxetine | |
| WO2011014003A3 (fr) | Dérivés de (+)-3-(+)-3-hydroxymorphinan utilisés comme neuroprotecteurs | |
| IL192963A0 (en) | Rimonabant monohydrate, process for the preparation thereof and pharmaceutical compositions containing same | |
| WO2009053549A8 (fr) | Le solvate de dmso de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant | |
| WO2009124734A3 (fr) | Dérivés de sulfonamide substitués | |
| PL1999112T3 (pl) | Podstawione 2-amino-4-fenylo-dihydrochinoliny, sposób ich wytwarzania, ich zastosowanie jako leku i lek je zawierający | |
| AP2012006352A0 (en) | AzabicycloÄ3.1.0Ühex-2-yl derivatives, method for preparing same, and pharmaceutical compositions containing same. | |
| WO2007139984A3 (fr) | Polymorphes de chlorhydrate de duloxétine | |
| EP1994003A4 (fr) | Dérivés de pipéridine, leur procédé de synthèse, leur emploi en tant qu'agents thérapeutiques et les compositions pharmaceutiques les incluant |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08842355 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 08842355 Country of ref document: EP Kind code of ref document: A1 |